Hematology-Oncology

Tourwellsoon provides a highly specialized Hematology-Oncology and Bone Marrow Transplant (BMT) program, offering patients access to some of the world’s most advanced cellular therapies, including CAR T-cell Therapy. By partnering with JCI and NABH-accredited hospitals in India, TourWellSoon ensures that life-saving treatments are both accessible and affordable.

Below is a comprehensive guide to the BMT and CAR T-cell therapy services offered by Tourwellsoon.

Our advanced Hematology-Oncology and Bone Marrow Transplant (BMT) program services include:

Comprehensive diagnosis and evaluation:

Before any transplant or cell therapy begins, TourWellSoon facilitates a rigorous diagnostic phase to ensure patient safety and treatment efficacy:

HLA typing: For allogeneic transplants, we coordinate high-resolution HLA matching to find a compatible donor (sibling, unrelated, or haploidentical match).
Organ function assessments: Comprehensive tests including Echo/ECG (heart), PFT (lungs), and renal/liver function tests to ensure the body can withstand conditioning therapy.
Disease status evaluation: Bone marrow aspiration, PET-CT scans, and flow cytometry to determine the current stage of the condition.

Treatment provided by us:

1. Bone Marrow Transplants (BMT):

Tourwellsoon facilitates all major types of bone marrow and hematopoietic stem cell transplants:

Autologous BMT: Uses the patient’s own healthy stem cells, typically for Multiple Myeloma or Lymphoma.
Allogeneic BMT (Matched Related): Uses stem cells from a genetically matched family member (sibling or parent).
Haploidentical transplant: A specialized “half-match” transplant, often used when a full match is unavailable.
Matched unrelated donor (MUD) BMT: Sourcing cells from international registries (like DATRI or Be The Match).

2. CAR T-Cell Therapy (Chimeric Antigen Receptor):

Tourwellsoon offers CAR T-cell Therapy (Chimeric Antigen Receptor T-cell Therapy) as a flagship part of its oncology and immunotherapy program. This revolutionary “living drug” treatment is primarily used for patients with aggressive blood cancers who have not responded to standard treatments like chemotherapy or bone marrow transplants.

By facilitating travel to India, Tourwellsoon helps patients access this therapy at a significantly lower cost—often $65,000 to $85000 compared to over $400,000 in the US or UK.

Often, CAR T-cell therapy is used as a “bridge” to BMT or as a standalone treatment for patients who have relapsed after a transplant.

A revolutionary immunotherapy where the patient’s T-cells are genetically “reprogrammed” to hunt and kill cancer cells.
Indigenous Solutions: In India, we provide access to affordable
CAR T-cell therapy that significantly lowers the cost compared to Western brands.

The CAR T-cell Therapy Process:

Leukapheresis (Cell Collection): T-cells are extracted from the patient’s blood using a specialized machine.
Genetic engineering: The cells are sent to a high-tech lab where they are “reprogrammed” with a CAR gene to recognize specific cancer proteins (like CD19 or BCMA).
Expansion: The modified cells are grown into the millions over 2–4 weeks.
Lymphodepletion: The patient undergoes “bridging” chemotherapy to clear out existing T-cells and make room for the new ones.
Infusion: The engineered CAR T-cells are infused back into the patient to begin attacking the cancer.

Conditions we treat:

1. Hematological malignancies (Cancers)

Leukemia: Including Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Chronic Myeloid Leukemia (CML).
Lymphoma: Both Hodgkin’s and Non-Hodgkin’s Lymphoma (including aggressive B-cell types).
Multiple myeloma: A cancer of the plasma cells, for which BMT is often a standard of care for long-term remission.
Myelodysplastic syndromes (MDS): Often referred to as “pre-leukemia” conditions.

2. Benign blood disorders & genetic conditions

Aplastic anemia: Where the bone marrow stops producing enough new blood cells.
Thalassemia & sickle cell anemia: Genetic disorders affecting hemoglobin production.
Immune deficiency disorders: Including SCID (Severe Combined Immunodeficiency).

3. Specialized CAR T-Cell indications

CAR T-cell therapy (Chimeric Antigen Receptor T-cell) is primarily offered for patients with relapsed or refractory (treatment-resistant) cancers:

B-cell Acute Lymphoblastic Leukemia (B-ALL)
Diffuse Large B-cell Lymphoma (DLBCL)
Mantle Cell Lymphoma and Follicular Lymphoma
Multiple Myeloma (targeting BCMA antigens)

Why choose TourWellSoon for your Advanced Hematology-Oncology treatment?

Expert Specialists: We connect you with top-tier hematologists and BMT surgeons who have performed thousands of successful transplants and have expertise in complex transplants.
Advanced Technology: We partner with JCI and NABH-accredited institutions that feature dedicated BMT units, ultra-sterile, HEPA-filtered isolation rooms to prevent post-transplant infections, in-house Stem Cell labs, and advanced facilities for cryopreservation and genetic engineering of T-cells.
Significant Cost Savings: Accessing BMT and CAR T-cell therapy through our network can save you 60% to 80% compared to costs in the US or Europe, without compromising on clinical quality.
Focus on Patient Comfort and Privacy: We provide a comfortable, private, and compassionate environment for all consultations and procedures.
International Patient Support: Our team is experienced in managing the needs of international patients, including medical visa assistance and language interpretation services.

Next Steps:

If you are experiencing any symptoms related to blood disorders or hematological cancers, please contact Tourwellsoon to schedule a consultation with one of our expert hematologists or oncologists. We will work with you to identify the precise cause of your concern, develop a personalized treatment plan utilizing advanced options such as Bone Marrow Transplant or targeted therapies and help you achieve optimal hematological health and long-term recovery.
For enquiries, kindly fill out the medical query form, or you can share your medical reports on our email help@tourwellsoon.com or our WhatsApp number +91-88105 22512.